Want to see HK:9996 full AI Analyst Report?
Peijia Medical Ltd. (9996) Ratios
Peijia Medical Ltd. Ratios
HK:9996's free cash flow for Q2 2026 was $-11.95M. For the 2026 fiscal year, HK:9996's free cash flow was decreased by $-42.54M and operating cash flow was $30.59M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.21 | 2.23 | 8.02 | 3.47 | 20.44 |
| Quick Ratio | 1.00 | 1.88 | 6.74 | 3.17 | 19.72 |
| Cash Ratio | 0.86 | 1.51 | 5.16 | 2.89 | 19.34 |
| Solvency Ratio | -0.17 | -0.27 | -0.88 | -0.55 | -3.78 |
| Operating Cash Flow Ratio | -0.03 | -0.01 | -3.78 | -0.65 | -3.68 |
| Short-Term Operating Cash Flow Coverage | -0.05 | -0.06 | -42.20 | -6.71 | 0.00 |
| Net Current Asset Value | $ 23.10M | $ 342.89M | $ 839.61M | $ 1.33B | $ 2.28B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.09 | 0.08 | 0.04 | 0.00 |
| Debt-to-Equity Ratio | 0.24 | 0.12 | 0.10 | 0.05 | 0.00 |
| Debt-to-Capital Ratio | 0.19 | 0.11 | 0.09 | 0.05 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.07 | 0.08 | 0.03 | 0.00 |
| Financial Leverage Ratio | 1.44 | 1.33 | 1.17 | 1.26 | 1.05 |
| Debt Service Coverage Ratio | -0.33 | -1.94 | -24.96 | -6.33 | -3062.17 |
| Interest Coverage Ratio | -16.93 | -50.54 | -2420.00 | -191.08 | -3219.36 |
| Debt to Market Cap | 0.12 | 0.10 | 0.05 | 0.02 | 0.00 |
| Interest Debt Per Share | 0.67 | 0.39 | 0.33 | 0.20 | 0.01 |
| Net Debt to EBITDA | 1.19 | 2.34 | 1.65 | 4.27 | 4.19 |
| Profitability Margins | |||||
| Gross Profit Margin | 68.18% | 70.45% | 73.76% | 70.25% | 70.06% |
| EBIT Margin | -27.51% | -37.32% | -88.71% | -157.84% | -420.43% |
| EBITDA Margin | -18.00% | -28.69% | -79.01% | -143.48% | -400.30% |
| Operating Profit Margin | -27.87% | -38.89% | -97.65% | -176.43% | -438.57% |
| Pretax Profit Margin | -28.42% | -36.00% | -88.75% | -158.76% | -420.57% |
| Net Profit Margin | -28.52% | -36.81% | -88.98% | -162.58% | -420.57% |
| Continuous Operations Profit Margin | -29.20% | -37.12% | -88.99% | -162.58% | -420.57% |
| Net Income Per EBT | 100.34% | 102.25% | 100.26% | 102.40% | 100.00% |
| EBT Per EBIT | 101.98% | 92.59% | 90.89% | 89.99% | 95.89% |
| Return on Assets (ROA) | -7.65% | -8.43% | -14.69% | -12.30% | -18.15% |
| Return on Equity (ROE) | -11.02% | -11.17% | -17.26% | -15.46% | -19.02% |
| Return on Capital Employed (ROCE) | -10.04% | -10.66% | -17.11% | -16.16% | -19.67% |
| Return on Invested Capital (ROIC) | -8.37% | -10.24% | -17.00% | -15.82% | -19.64% |
| Return on Tangible Assets | -10.77% | -11.15% | -18.31% | -14.68% | -19.89% |
| Earnings Yield | -5.66% | -9.05% | -8.63% | -7.18% | -8.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.43 | 27.56 | 5.50 | 19.92 | 0.00 |
| Payables Turnover | 0.79 | 7.07 | 5.87 | 0.21 | 0.75 |
| Inventory Turnover | 1.55 | 1.16 | 0.58 | 0.43 | 0.48 |
| Fixed Asset Turnover | 0.94 | 0.88 | 0.96 | 0.77 | 0.85 |
| Asset Turnover | 0.27 | 0.23 | 0.17 | 0.08 | 0.04 |
| Working Capital Turnover Ratio | 2.07 | 0.76 | 0.35 | 0.13 | 0.06 |
| Cash Conversion Cycle | -200.87 | 276.33 | 628.92 | -903.02 | 283.92 |
| Days of Sales Outstanding | 23.66 | 13.25 | 66.37 | 18.33 | 0.00 |
| Days of Inventory Outstanding | 234.90 | 314.71 | 624.69 | 847.02 | 767.56 |
| Days of Payables Outstanding | 459.43 | 51.62 | 62.14 | 1768.37 | 483.64 |
| Operating Cycle | 258.56 | 327.95 | 691.06 | 865.35 | 767.56 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.01 | -0.86 | -0.56 | -0.66 |
| Free Cash Flow Per Share | -0.49 | -0.43 | -1.32 | -0.75 | -0.76 |
| Dividend Paid and CapEx Coverage Ratio | -0.07 | -0.02 | -1.85 | -2.88 | -6.26 |
| Capital Expenditure Coverage Ratio | -0.07 | -0.02 | -1.85 | -2.88 | -6.26 |
| Operating Cash Flow Coverage Ratio | -0.05 | -0.02 | -2.64 | -2.85 | -57.21 |
| Operating Cash Flow to Sales Ratio | -0.03 | -0.01 | -1.32 | -1.50 | -3.20 |
| Free Cash Flow Yield | -9.06% | -11.40% | -19.78% | -8.92% | -7.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -17.41 | -11.05 | -11.59 | -13.93 | -12.48 |
| Price-to-Sales (P/S) Ratio | 5.04 | 4.07 | 10.31 | 22.65 | 52.49 |
| Price-to-Book (P/B) Ratio | 1.95 | 1.23 | 2.00 | 2.15 | 2.37 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.04 | -8.77 | -5.06 | -11.22 | -14.16 |
| Price-to-Operating Cash Flow Ratio | -171.89 | -483.12 | -7.80 | -15.11 | -16.42 |
| Price-to-Earnings Growth (PEG) Ratio | 1.97 | 0.27 | 2.36 | 0.47 | 0.16 |
| Enterprise Value Multiple | -26.80 | -11.83 | -11.40 | -11.52 | -8.93 |
| Enterprise Value | 3.44B | 2.09B | 3.97B | 4.14B | 4.88B |
| EV to EBITDA | -26.80 | -11.83 | -11.40 | -11.52 | -8.93 |
| EV to Sales | 4.82 | 3.39 | 9.01 | 16.52 | 35.73 |
| EV to Free Cash Flow | -10.57 | -7.32 | -4.42 | -8.18 | -9.64 |
| EV to Operating Cash Flow | -164.57 | -403.33 | -6.81 | -11.02 | -11.18 |
| Tangible Book Value Per Share | 1.64 | 2.07 | 2.57 | 3.12 | 4.15 |
| Shareholders’ Equity Per Share | 2.77 | 3.03 | 3.35 | 3.92 | 4.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | -0.03 | -0.00 | -0.02 | -0.04 |
| Revenue Per Share | 1.07 | 0.92 | 0.65 | 0.37 | 0.21 |
| Net Income Per Share | -0.31 | -0.34 | -0.58 | -0.61 | -0.87 |
| Tax Burden | 1.00 | 1.02 | 1.00 | 1.02 | 1.00 |
| Interest Burden | 1.03 | 0.96 | 1.00 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.37 | 0.38 | 0.67 | 1.49 | 3.33 |
| SG&A to Revenue | 0.63 | 0.78 | 0.32 | 0.49 | 0.84 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.06 | 0.11 | 0.23 |
| Income Quality | 0.10 | 0.02 | 1.49 | 0.92 | 0.76 |
Currency in CNY
